Trial intelligence / Profile preview

Antibiotics versus wound care alone after incision and drainage of pediatric subcutaneous abscess

ACTRN12626000388314Phase 4Completed

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of amoxicillin + clavulanate in cutaneous abscess (2 arms), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Clinical cure. Started Jun 2025; status: completed.

02

Drugs

amoxicillin + clavulanate
03

Conditions

cutaneous abscess

Beyond the preview

Go deeper on ACTRN12626000388314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12626000388314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call